Crohn's Pre-screening Clinical Research Questions

Home
Studies
About
- Therapeutic Areas
Our Team
Contact
- Apply for a Study
FAQ
Book Online
More

Use tab to navigate through the menu items.

Complete Our Pre-screener Questions

to See if You Qualify

All information is kept strictly confidential and HIPAA compliant.

We will contact you to let you know whether or not you qualify. If you do not qualify at this time, you can choose to be contacted again to notify you of new studies for which you may be eligible.

Are you currently taking any of the following medications? Please select all that apply.

Entvyio (vedolizumab)

Humira or Amjevita (adalimumab)

Enbrel or Ereizi (etanercept)

Remicade (infliximab)

Simponi (golimumab)

Cimzia (certolizumab pegol)

Not taking any of the above

How long ago were you diagnosed with Crohn's?

Less than 3 months ago

3-6 months ago

6-12 months ago

More than 1 year ago

Not Sure

You are completing this form for a current Crohn's Disease study. Do you also have Ulcerative Colitis (UC)?

Have you taken any of the following medications to treat Crohn's? Check all that apply.

Oral aminosalicylates

Oral corticosteroids

Azathioprine

Methotrexate

Not taking any of the above

If you were taking any of the above but stopped, please indicate when you stopped the treatment and describe if any of these treatments caused intolerance or were ineffective in treatment of UC

Any other information you'd like to provide?

Thanks for submitting! We will get back to you soon to let you know if you qualify!

851 Broken Sound Pkwy NW, Suite 125, Boca Raton, FL 33487

BOCA RATON: 561-334-2126

19 West Flagler Street, Suite M104, Miami, FL 33130

MIAMI: 305-503-9006

Complete Our Pre-screener Questions

to See if You Qualify

​

All information is kept strictly confidential and HIPAA compliant.

We will contact you to let you know whether or not you qualify. If you do not qualify at this time, you can choose to be contacted again to notify you of new studies for which you may be eligible.

​